Home
Clinical Trials
The Relationship Between GBS ...

The Relationship Between GBS Screening in Pregnant Women Insured in Maccabi Healthcare Services (MHS) and Early-onset Neonatal Disease in Israel

Last Updated: 2020-01-13

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

54759 participants

Study Classification

OBSERVATIONAL

Study Start Date

2015-01-01

Study Completion Date

2019-09-20

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Determination of GBS colonization rates in Pregnant Women insured with Maccabi Health Services, Doctors' Compliance Rates for Referral for Testing, test execution rates, and Early-onset GBS Disease (EOGBSD) Rates in Israel. Determine the relationship between conducting a GBS test in pregnant women and EOGBSD in Israel.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Group B Streptococcal Carrier State Prevalence Among Arab Pregnant Women in Northern Israel District

NCT02528890

Streptococcus B Carrier State Complicating Pregnancy

COMPLETED

Long Term Follow-up of Patients With Group A Streptococcal Infection Originating From the Genital Tract

NCT00299663

Streptococcal Infections

COMPLETED

Evaluation of a Serology Diagnostic Kit for the Detection of Genital Mycoplasma in Pregnancy

NCT01281319

Genital Mycoplasma Infection High Risk Pregnancy Preterm Labor

UNKNOWN

Effectiveness of Intrapartum Group B Streptococcus (GBS) Polimerase Chain Reaction Reaction (PCR) Screening

NCT01833780

GBS

UNKNOWN

Development and Optimization of a GBS Diagnostic Test

NCT00322829

Streptococcus Group B

COMPLETED

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

There have been few studies in recent years, which has prompted us to undertake this study. Our aim was to examine the current colonization rates and attack rates in the Israeli population. Our secondary aim was to evaluate the need to readjust recommendations towards universal screening.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Streptococcal Infection Group B as Cause of Diseases Classified Elsewhere (Diagnosis)

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

OTHER

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Women screened for GBS

All women who were pregnant during 2015-2016 and delivery was between 37-42 weeks who were screened for GBS during pregnancy

No interventions assigned to this group

Women not screened for GBS

All women who were pregnant during 2015-2016 and delivery was between 37-42 weeks who were not screened for GBS during pregnancy

No interventions assigned to this group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* All women with term pregnancies from 2015 to 2016 (until 20/9/16) insured by Maccabi Healthcare Services (MHS)

Exclusion Criteria

* repeat pregnancies occurring in the same woman during the time period
* multiple pregnancies
* gestational age greater than 42 weeks due to probability of data inaccuracy
* women with missing information

Eligible Sex

FEMALE

Accepts Healthy Volunteers